文献速递前列腺癌

初始Gleason分级对前列腺癌主动监测结局的影响

Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.
PubMed 文献 · Eur Urol Oncol · 2018-05-24

该回顾性研究纳入1990至2016年间接受主动监测且至少两次活检的1243例前列腺癌患者,其中初始Gleason 3+3者1119例(90%),3+4者124例(10%)。5年未调整的免再分级生存率两组均为49%,但Gleason 3+4组治疗-free生存率更低(49% vs 64%,p<0.01)。多因素分析显示初始分级与再分级风险降低(HR 0.66,95%CI 0.46-0.95)和治疗风险升高(HR 1.37,95%CI 1.01-1.85)相关。

要点

  • 初始Gleason 3+4与再分级风险降低相关(HR 0.66,95%CI 0.46-0.95)。
  • 初始Gleason 3+4与治疗风险升高相关(HR 1.37,95%CI 1.01-1.85)。
  • 根治性前列腺切除术后,初始Gleason 3+4组2年无生化复发生存率更低(69% vs 93%,p=0.01)。

核心结论

  • 诊断时Gleason 3+4与再分级、治疗和生化复发风险相关,高级别穿刺针数可能有助于对Gleason 3+4患者进行分层。

研究设计与样本

  • 回顾性研究,纳入1990年至2016年间接受主动监测、初始Gleason 3+3或3+4且至少有两次活检的前列腺癌患者1243例。

主要发现

  • 1243例中1119例(90%)初始活检为Gleason 3+3,124例(10%)为3+4。
  • 5年未调整的免再分级生存率两组均为49%,Gleason 3+4组治疗-free生存率更低(49% vs 64%,p<0.01)。
  • 多因素Cox分析显示,分级与再分级风险降低相关(HR 0.66,95%CI 0.46-0.95),与治疗风险升高相关(HR 1.37,95%CI 1.01-1.85)。
  • 根治性前列腺切除术后,初始Gleason 3+4组未调整2年无生化复发生存率更低(69% vs 93%,p=0.01),复发风险更高(HR 3.67,95%CI 1.30-10.36)。
  • 分级与转移(5年时<1%)或不良病理无关。

关键数值与推荐

  • 敏感性分析中,单根高级别穿刺针与再分级风险降低相关,多根高级别穿刺针与治疗风险升高相关,高级别穿刺针数与生化复发无独立关联。

临床怎么用

  • 部分Gleason 3+4前列腺癌患者可能适合作为主动监测候选者,但需要更长随访和评估更多患者。

局限性

  • 选择偏倚
  • 中危患者数量有限
  • 随访时间长度

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether men with Gleason 3+4 prostate cancer are appropriate active surveillance (AS) candidates remains a matter of debate. OBJECTIVE: to evaluate the effects of initial Gleason grade 3+3 or 3+4 on clinical outcomes during AS. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively reviewed outcomes for men on AS between 1990 and 2016 with Gleason 3+3 or 3+4 who had two or more biopsies. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We evaluated associations of diagnostic grade with reclassification (upgrade ≥ 3+4), treatment, metastasis, adverse surgical pathology, and biochemical recurrence (BCR) after deferred radical prostatectomy (RP), with a sensitivity analysis for the amount of pattern 4 disease. RESULTS AND LIMITATIONS: Of 1243 men, 1119 (90%) had Gleason 3+3 and 124 (10%) 3+4 on initial biopsy. The 5-yr unadjusted reclassification-free survival was 49% regardless of grade, while patients with Gleason 3+4 had lower treatment-free survival (49% vs 64%; p<0.01). On multivariate Cox analysis, grade was associated with lower risk of reclassification (hazard ratio [HR] 0.66, 95% confidence interval [CI] 0.46-0.95) and higher risk of treatment (HR 1.37, 95% CI 1.01-1.85). After RP, patients starting with Gleason 3+4 had lower unadjusted 2-yr BCR-free survival (69% vs 93%; p=0.01) and a higher risk of recurrence (HR 3.67, 95% CI 1.30-10.36). Grade was not associated with metastasis (<1% at 5 yr) or adverse pathology. In sensitivity analyses, a single high-grade core was associated with lower risk of reclassification and multiple high-grade cores were associated with a higher risk of treatment. The number of high-grade cores was not independently associated with BCR. Limitations include selection bias, a limited number of intermediate-risk patients, and length of follow-up. CONCLUSIONS: Gleason 3+4 at diagnosis was associated with risk of reclassification, treatment, and BCR. The number of high-grade cores may help in stratifying men with Gleason 3+4 disease. PATIENT SUMMARY: Some men with Gleason 3+4 prostate cancer may be appropriate surveillance candidates, but longer follow-up and evaluation of more patients are necessary.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Masic S, Cowan JE, Washington SL, et al. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018. PMID: 31158077. doi:10.1016/j.euo.2018.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。